Detalhe da pesquisa
1.
Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials.
Clin Gastroenterol Hepatol
; 21(3): 723-731.e9, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750249
2.
Reductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis.
Pain Med
; 24(3): 341-350, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102822
3.
Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation.
Curr Ther Res Clin Exp
; 98: 100694, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36875317
4.
First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis.
J Emerg Med
; 62(2): 231-239, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893381
5.
The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies.
Support Care Cancer
; 29(9): 5209-5218, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33629189
6.
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Prostate
; 80(1): 99-108, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31742767
7.
Immunogenicity and skin clearance recapture in clinical studies of brodalumab.
J Am Acad Dermatol
; 82(2): 344-351, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31175910
8.
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.
Prostate
; 79(6): 604-613, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663074
9.
Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials.
J Am Acad Dermatol
; 78(1): 81-89.e5, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985956
10.
Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.
Pain Med
; 18(8): 1496-1504, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28810695
11.
Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
Pain Pract
; 17(6): 820-828, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27860208
12.
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial.
Clin Transl Sci
; 16(1): 165-174, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36326174
13.
Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials.
J Pain Res
; 16: 395-406, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36798078
14.
Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose.
J Pain Res
; 16: 2595-2607, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533563
15.
Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness.
J Pain Res
; 16: 3529-3543, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37881233
16.
A Randomized, Double-Blind, Parallel Design Thorough QT Study With a Nested Crossover to Compare the Cardiac Safety of Amiselimod With Placebo and Positive Control in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 12(3): 236-248, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708138
17.
Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin.
Antimicrob Agents Chemother
; 61(1)2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27795384
18.
A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin.
Clin Transl Sci
; 15(9): 2159-2171, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35677972
19.
Methylnaltrexone for opioid-induced constipation in advanced illness.
N Engl J Med
; 358(22): 2332-43, 2008 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-18509120
20.
Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials.
F1000Res
; 10: 891, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34631030